Intuitive Surgical, Inc. (NASDAQ: ISRG) reported its Q3 results, with revenue coming in at $1.40 billion, beating the consensus estimate of $1.38 billion, on higher placements and procedures, despite $23 million of COVID- related customer credits.

The company delivered GAAP EPS of $1.04, which also beat the Street estimate of $0.88 on the higher revenues, OpEx leverage and lower-than-modeled tax rate.

The company trimmed its FY21 procedure growth guidance from 27-30% to 27-29%, mentioning that supply chain issues likely to impact margins going forward.